Studies of the Interaction between Human Protein S and Human C4b-Binding Protein Using Deletion Variants of Recombinant Human Protein S

Summary

Human protein S interacts noncovalently with human C4b-binding protein (C4BP). We have studied this interaction using deletion variants of recombinant human protein S. Two deletion variants were constructed by restriction enzyme digestion and in vitro site-specific mutagenesis of the human protein S cDNA. The variants were stably expressed in Cl27 cells. Recombinant proteins were purified using Fast Flow Q anion-exchange chromatography. The activated protein C (APC) cofactor activity, C4BP binding properties and reactivity to different monoclonal antibodies against human protein S were examined. The first variant (E variant), which has a deletion of the third epidermal growth factor (EGF)-like domain (deletion of exon VII, corresponding to amino acid residues ASP-160 to Asp-202) expresses normal APC cofactor • activity in a plasma system. This activity was inhibited by the addition of purified C4BP. The second variant (L variant), which has a deletion of the C-terminal loop of the sex hormone binding globulin (SHBG)- like domain (deletion of exon XV, corresponding to amino acid residues Asp-583 to Ser-635) also expresses normal APC cofactor activity in plasma. This activity could only be partially inhibited by the addition of purified C4BP.

Binding of the recombinant proteins to C4BP was studied in a system using purified proteins. The E variant binds to C4BP with the same affinity similar as recombinant wild type protein S (apparent K_d ∼ 10⁻¹⁰ M). The L variant, however, shows a markedly reduced affinity for binding to C4BP (apparent K_d ∼ 10⁻⁷ M).

Three different Ca²⁺-independent monoclonal antibodies (S5, S12, S17) against protein S, which do not interfere with the APC cofactor activity and C4BP binding of protein S, were used to screen the deletion variants for possible conformational changes. Two of these showed the same affinity for the E and L variant as for wild type recombinant protein S. The third, S12, which recognizes an epitope in the vicinity of ser-460, reacts normally with the E variant but has a strongly reduced affinity for the L variant, although the presence of the epitope could be clearly demonstrated by immunoblotting under denaturing conditions.

This suggests that the deletion of the C-terminal loop induces a conformational change in protein S which affects the epitope for S12. Therefore although our results indicate that the C-terminal loop of the SHBG-like domain of human protein S is involved in the interaction with C4BP, we cannot exclude the possibility that the deletion of the C-terminal loop induces a conformational change that results in a loss of binding affinity for C4BP elsewhere in the protein S molecule.

• References

• 1 Di Scipio RG, Hermodson MA, Yates SG, Davie EW. A comparison of human prothrombin, Factor IX (Christmas Factor), Factor X (Stuart Factor), and protein. S. Biochemistry 1977 16: 698-706
• 2 Di Scipo RG, Davie EW. Characterization of protein S. a γ-carboxyglu- tamic acid containing protein from bovine and human plasma. Biochemistry 1979; 18: 899-904
• 3 Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255: 5521-4
• 4 Gardiner JE, McGann MA, Berridge CW, Fulcher CA, Zimmerman TS, Griffin JH. Protein S as a cofactor for activated protein C in plasma and in the inactivation of purified factor VIII:C. Circulation 1984; 70: 11-205 (abstract).
• 5 Koedam JA, Meijers JCM, Sixma JJ, Bouma BN. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 1988; 82: 1236-43
• 6 Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082-8
• 7 Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-300
• 8 Engesser L, Broekmans AW, Brief E, Brommer EJ, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987; 106: 677-82
• 9 Dahlback B, Lundwall A, Stenflo J. Primary structure of bovine vitamin K-dependentprotein. Proc Natl Acad Sci USA 1986 83: 4199-203
• 10 Lundwall A, Dackowski W, Cohen E, Shaffer M, Mahr A, Dahlback B, Stenflo J, Wydro R. Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation. Proc Natl Acad Sci USA 1986; 83: 6716-20
• 11 Hoskins J, Norman DK, Beckmann RJ, Long GL. Cloning and characterization of human liver cDNA encuding a protein S precursor. Proc Natl Acad Sci USA 1987; 84: 349-53
• 12 Ploos van Amstel HK, van der Zanden AL, Reitsma PH, Bertma RM. Human protein S cDNA encodes Phe-16 and Tyr 222 in consensus sequences for the post-translational processing. FEBS Lett 1987; b 222: 186-90
• 13 Schmidel DK, Tatro AV, Phelps LG, Tomczak JA, Long GL. Organization of the human protein S genes. Biochemistry 1990; 29: 7845-52
• 14 Ploos van Amstel HK, Reitsma PH, van der Logt CP, Bertina RM. Intronexon organization of the active human protein S gene PSa and its pseudogene PSB: duplication and silencing during primate evolution. Biochemistry 1990; 29: 7853-61
• 15 Edenbrandt CM, Lundwall A, Wydro R, Stenflo J. Molecular analysis of the gene for vitamin K dependent protein S and its pseudogene. Cloning and partial gene organization. Biochemistry 1990; 29: 7861-8
• 16 Dahlback B. Inhibition of protein C_a cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 1986; a 261: 12022-7
• 17 Bertina RM, van Wijngaarden A, Reinalda-Poot J, Poort SR, Bom VJJ. Determination of plasma protein S - the protein cofactor of activated protein C. Thromb Haemost 1985; 53: 268-72
• 18 Nagasawa S, Ichihara C, Stroud RM. Cleavage of C4b by C3b inactivator: production of a nicked form of C4b. C4b' as an intermediate cleavage product of C4b by C3b inactivator. J Immunol 1980 125: 578-82
• 19 Fujita T, Gigli I, Nussenzweig V. Human C4b-binding protein. II. Role in proteolysis of C4b by C3b-inactivator. J Exp Med 1979; 148: 1044-51
• 20 Gigli I, Fujita T, Nussenzweig V. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein an C3b inactivator. Proc Natl Acad Sci USA 1979; 76: 6596-6600
• 21 Scharfstein J, Ferreira A, Gigli I, Nussenzweig V. Fluman C4b-binding protein. Isolation and characterization. j Exp Med 1978; 148: 207-22
• 22 Reid KBM, Gagnon J. Human C4 binding protein: N-terminal aminoacid sequence analysis and limited proteolysis by trypsin. FEBS Letters 1982; 137: 75-9
• 23 Dahlback B, Smith CA, Miiller-Eberhard HJ. Visualization of human C4bbinding protein and its complexes with vitamin K-dependent protein S and complement protein C4b. Proc Natl Acad Sci USA 1983; 80: 3461-5
• 24 Hillarp A, Dahlback B. Novel subunit in C4b-binding protein required for protein S binding. J Biol Chem 1988; 263: 12759-12764
• 25 Hillarp A, Hessing M, Dahlback B. Protein S binding in relation to the subunit composition of human C4b-binding protein. FEBS Lett 1989; 259: 53-6
• 26 Suzuki K, Nishioka J. Binding site for vitamin K-dependent protein S on complement C4b-binding protein. J Biol Chem 1988; 263: 17034-9
• 27 Hardig Y, Rezaie A, Dahlback B. High affinity binding of human vitamin K-dependent protein S to a truncated recombinant β-chain of C4b-binding protein expressed Escherichia coli . J Biol Chem 1993; 268: 3033-6
• 28 Walker FJ. Characterization of a synthetic peptide that inhibits the interaction between protein S and C4b-binding protein. J Biol Chem 1989; 264: 17645-8
• 29 Fernandez JA, Griffin JH. Identification of regions of protein S essential for binding to C4b binding protein. Thromb Haemost 1991; 65: 711
• 30 Chang GTG, Ploos van Amstel HK, Hessing M, Reitsma PH, Bertina RM, Bouma BN. Expression and characterization of recombinant human protein S in heterologous cells - Studies of the interaction of amino acid residues Leu-608 to Glu-612 with human C4b-binding protein. Thromb Haemost 1992; 67: 526-32
• 31 Nelson RM, Long GL. Binding of protein S to C4b-binding protein. Mutagenesis of protein S. J Biol Chem 1992; 267: 8140-5
• 32 Hessing M, Vlooswijk RAA, Hackeng TM, Kanters D, Bouma BN. The localization of heparin binding fragments on human C4b binding protein. J Immunol 1990; 144: 204-8
• 33 Nakane PK, Kawaoi A. Peroxidase-labeled antibody a new method of conjugation. J Histochem Cytochem 1974; 22: 1084-91
• 34 Sambrook J, Fritz EF, Maniatis T. Molecular Cloning: a laboratory manual. Cold Spring Harbour Laboratory. Press Cold Spring Harbor New York. 1989
• 35 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 76: 5463-7
• 36 Kunkel TA. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 1985; 82: 488-92
• 37 Graham F, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus. Virology 1983; 52: 456-67
• 38 Grinnell BW, Walls JD, Marks C, Glasebrook AL, Berg DT, Yan BS, Bang NU. γ-carboxylated isoforms of recombinant human protein S with different biologic properties. Blood 1990; 76: 2546-54
• 39 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5
• 40 Morrisey JH. Silverstain for proteins in polyacryl amide gels. A modified procedure with enhanced uniform sensitivity. Anal Biochem 1981; 117: 307-10
• 41 Deutz-Terlouw PP, Ballering L, van Wijngaarden A, Bertina RM. Two ELISA’s for measurement of protein S and their use in the laboratory diagnosis of protein S deficiency. Clin Chim Acta 1989; 186: 321-34
• 42 Dahlback B, Frohm B, Nelsestuen G. High affinity interaction between C4b-binding protein and vitamin K-dependent protein S in the presence of calcium. Suggestion of a third component in blood regulating the interaction. J Biol Chem 1990; a 265: 16082-7
• 43 Nelson RM, Long GL. Solution-phase equilibrium binding interaction of human protein S with C4b-binding protein. Biochemistry 1991; a 30: 2384-90
• 44 Griffin JH, Gruber A, Fernandez JA. Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate and hirudin. Blood 1992; 79: 3203-11
• 45 Bertina RM, Ploos van Amstel HK, van Wijngaarden A, Coenen J, Leemhuis MP, Deutz-Terlouw PP, van der Linde IK, Reitsma PH. Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460. Blood 1990; 76: 538-48